December 24, 2021
Partnering to build biosynthesis processes and a pharmaceutical production platform Tokyo, Japan - Yokogawa Electric Corporation (TOKYO: 6841) announces that it has invested in GlyTech, Inc., a Kyoto-based company with leading-edge technologies in the synthesis of glycans, which influence cell metabolism and functional changes. The companies will partner with the aim of establishing biosynthesis processes that [...]
December 23, 2021
SAN DIEGO -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of the leading software solutions for visualization, interpretation and reporting of genomic data, today announced that University Hospitals Leuven in Belgium, after previously receiving its accreditation from the Belgian Accreditation Body (BELAC) for using OGM in analysis [...]
Introducing the premier solution for multiphoton imaging: The Scientifica VistaScope
December 23, 2021
See more cells, more clearly than ever before. With the largest in-class field of view, Scientifica’s latest addition to our modular portfolio of multiphoton imaging solutions, the VistaScope, is an industry-leading development. The VistaScope will enable researchers to see more cells simultaneously - in fact, twice as many cells - compared to the closest competitor. The monumental [...]
Qlucore announces major new release for bioinformatics
December 23, 2021
Version 3.8 of Qlucore Omics Explorer enables faster and improved data visualizations. Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools, announces Qlucore Omics Explorer (QOE) version 3.8, with new features that will improve ease of use and enhance performance. Qlucore Omics Explorer is a next-generation bioinformatics software for research in life science, [...]
December 23, 2021
Researchers around the world can utilize the synthetic genome to produce virus to test strain-specific diagnostics, monoclonal antibody treatments, small-molecule therapies, or new vaccines against the highly transmissible variant SAN DIEGO -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the release of a new full-length synthetic genome [...]
December 23, 2021
Cytiva has been awarded a USD 147.6 million contract from the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in coordination with the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, [...]
December 23, 2021
Creator of an entirely new industry segment as the premier air filtration specialist motivated by innovation with a strong focus on R&D, ERLAB has grown organically for the past 53 years by inventing and developing its own chemical filtration technology products specially tailored for the handling and storage of toxic gases used in laboratories. Wanting [...]
HTG Completes HTP Product Next-Phase Development Milestone
December 22, 2021
Expands Potential Market and Study Opportunities for HTG Transcriptome Panel TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has now expanded the potential markets and applications for its pioneering HTG Transcriptome Panel (HTP). Since launching HTP with commercial availability in [...]
Nanalysis Establishes Scientific Advisory Board with Four World Renowned Scientists
December 22, 2021
CALGARY, AB - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") is pleased to announce that, effective December 21, 2021, it has established a Scientific Advisory Board, with four world renowned scientists as founding members, including Dr. Matt Rosen of Harvard Medical School and co-founder of Hyperfine. Nanalysis is a leader in miniaturized magnetic resonance systems for industrial [...]
908 Devices Teams With World-Renowned Guardian Centers of Georgia for First Responder Training
December 22, 2021
Premier CBRNE training facility uses 908 Devices MX908 portable mass spec devices for trace detection of hazardous chemicals BOSTON -- 908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it is teaming with Guardian Centers of Georgia, a world-renowned training facility that specializes in Chemical, Biological, [...]

